The event focused on emerging advances in medicinal chemistry, drug design, target identification, computational drug discovery and more, with discussions aimed at bridging fundamental research and clinical applications
The inspection was conducted at Lannett Company's manufacturing facility in Seymour, Indiana, USA, from August 17 to 21, 2026
This marks the first province-wide deployment of an integrated Health Kiosk and digital clinic management model in the country
Under the collaboration, Atomy India and PCI will organise nutrition and wellness awareness programmes, including seminars, workshops, athlete interactions, community engagement initiatives and digital campaigns
The proposed facility will add annual capacity of 1,464 million baby diapers, 252 million adult diapers and 192 million sanitary napkins
100+ senior leaders participate in the National Skill Summit in Hyderabad to address emerging skill gaps, strengthening training ecosystems and building an industry-aligned workforce
The company said it believes the observations are procedural in nature and expressed confidence that it will address them comprehensively within the stipulated timelines
The three-day exhibition, being held from August 21–23, features more than 300 domestic and international brandsand is expected to attract over 8,000 healthcare and medtech professionals
The archive currently spans the period from 1901 to 2025, featuring more than 250 video stories, profiles of over 30 industry leaders and nearly 1,000 documents and resources
The company clarified that all 10 observations are strictly procedural in nature
Sheltidin DS is a herbal throat-soothing spray designed to offer fast relief from dry and irritating coughs, sore throat, throat irritation
Saransh Chaudhary appointed Executive Director; Gurminder Singh Bedi joins as Independent Director, while Manu Chaudhary and Savita Gupta secure second terms
Operating income rises 21.2% to Rs. 186.1 crore as EBITDA margin expands to 17.9%; company targets Rs. 1,500 crore revenue and Rs. 200 crore+ net profit by FY30
The company announced the launch of 1,000 mg/10 mL and 5,000 mg/50 mL single-dose vials
A clinical study involving 138 Indian women aged 40-60 evaluated Fenavari at 300 mg and 500 mg doses
Company adds 246 net stores in Q1; customer footfall rises to 60 lakh as management targets 600-650 new outlets in FY27 and cash breakeven by Q4 FY27 or Q1 FY28
THIP Academy recognised for evidence-based vaccination education as platform expands courses on adult, paediatric and HPV vaccination
The trial met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival, marking what the companies describe as the first positive Phase 3 readout
Subscribe To Our Newsletter & Stay Updated
